4.6 (624) · € 41.00 · En Stock
Pfizer Hospital US
Relyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment • BioPharma Media
lifeform – Page 14 – Nasco Healthcare
Cemiplimab-rwlc Injection, for Intravenous Use (Libtayo®) HCPCS Code J9999: Billing Guidelines
lifeform – Page 14 – Nasco Healthcare
Respimer Netiflow® nasal irrigator - Laboratoire de la Mer
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial - The Lancet
lifeform – Page 14 – Nasco Healthcare
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial - The Lancet Oncology
Xarelto® – Indications
Xarelto® – Indications